Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT02804594 A Study of Oxidative Pathways in MS Fatigue |
N-acetyl cysteine | SEP | Phase 2 | COMPLETED | En attente / non publié | University of California, San Fra… | United States · University of California San Francisc… | 2016-10-01 → 2018-06-01 | Ouvrir |
| NCT04544436 MUSETTE — A Study to Evaluate the Efficacy, Safety and Pharmacokinetics… |
Ocrelizumab | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Argentina, Australia, Belgium, Brazil,… | 2020-11-26 → 2028-08-31 | Ouvrir |
| NCT05344469 AIOLOS — A NIS Evaluating Various Injectable and Oral Treatments in Pat… |
AIOLOS — A NIS Evaluating Various… | SEP | À vérifier | RECRUITING | En attente / non publié | Novartis Pharmaceuticals | Germany · Novartis Investigative Site, Aalen, Germany… | 2022-05-10 → 2029-05-30 | Ouvrir |
| NCT07501520 HistaMed-MS — Effect of Low Histamine-Based Modified Mediterranean Diet… |
HistaMed-MS — Effect of Low Hista… | SEP | Non applicable | COMPLETED | En attente / non publié | Firat University | Turkey (Türkiye) · Firat University Hospital, Neurolo… | 2024-06-15 → 2025-06-10 | Ouvrir |
| NCT07738978 Understanding and Enhancing Human Health and Movement |
Neural Prosthesis | SEP | Non applicable | RECRUITING | En attente / non publié | Louis Stokes VA Medical Center | United States · Louis Stokes Cleveland VA Medical Cen… | 2021-03-21 → 2034-03-21 | Ouvrir |
| NCT07736482 Relationship Between Single- and Dual-Task Obstacle Crossing Performanc… |
Relationship Between Single- and … | SEP | À vérifier | RECRUITING | En attente / non publié | Afyonkarahisar Health Sciences Un… | Turkey (Türkiye) · Afyonkarahisar Health Sciences Uni… | 2026-03-20 → 2027-02-20 | Ouvrir |
| NCT07738120 Immersive Virtual Reality and Exercise Programs in Multiple Sclerosis: … |
Immersive Virtual Reality and Exe… | SEP | Non applicable | RECRUITING | En attente / non publié | University of Vigo | Spain · University of Vigo, Pontevedra, Spain | 2025-10-06 → 2026-08-07 | Ouvrir |
| NCT07743281 A Study of Treatment Patterns and Annualized Relapse Rate in Multiple S… |
A Study of Treatment Patterns and… | SEP | À vérifier | COMPLETED | En attente / non publié | Novartis Pharmaceuticals | United States · Novartis, East Hanover, United States | 2025-03-10 → 2025-07-30 | Ouvrir |
| NCT07741864 Effectiveness of a Mindfulness-Based Intervention for Pain Management i… |
Effectiveness of a Mindfulness-Ba… | SEP | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Hospital Universitario Virgen Mac… | Spain · Hopsital Universitario Virgen Macarena, Sevil… | 2026-09-02 → 2027-04-30 | Ouvrir |
| NCT07742579 Online Mindfulness-Based Cognitive Therapy for People With Multiple Scl… |
Online Mindfulness-Based Cognitiv… | SEP | Phase 3 | NOT_YET_RECRUITING | En attente / non publié | Robert Simpson | Non communiqué | 2026-08 → 2028-12 | Ouvrir |
| NCT05189106 Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis… |
Baricitinib | Sclérose latérale amyotrophique | Phase 1/2 | COMPLETED | En attente / non publié | Massachusetts General Hospital | United States · Massachusetts General Hospital - AD S… | 2022-12-05 → 2025-06-20 | Ouvrir |
| NCT02478450 Study to Investigate the Safety of the Transplantation (by Injection) o… |
Q-Cells | Sclérose latérale amyotrophique | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | Q Therapeutics, Inc. | Non communiqué | 2026-12 → 2029-12 | Ouvrir |
| NCT07017946 Intestinal Microbiome Transplant in ALS |
MTP-101C | Sclérose latérale amyotrophique | Phase 1/2 | RECRUITING | En attente / non publié | Duke University | United States · Duke University Medical Center, Durha… | 2026-01-27 → 2026-11-01 | Ouvrir |
| NCT06392126 Personalized Antisense Oligonucleotide Therapy for A Single Participant… |
nL-CHCHD-001 | Sclérose latérale amyotrophique | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | n-Lorem Foundation | United States · Mayo Clinic, Jacksonville, United Sta… | 2024-04-16 → 2027-04 | Ouvrir |
| NCT07095686 Personalized Antisense Oligonucleotide for Participants With CHCHD10 ALS |
nL-CHCHD-001 | Sclérose latérale amyotrophique | Phase 1/2 | ENROLLING_BY_INVITATION | En attente / non publié | n-Lorem Foundation | United States · Columbia University, Irving Medical C… | 2024-10-02 → 2027-04 | Ouvrir |
| NCT06977451 Personalized Antisense Oligonucleotide for a Single Participant With CH… |
nL-CHCHD-001 | Sclérose latérale amyotrophique | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | n-Lorem Foundation | United States · Columbia University, Irving Medical C… | 2024-06-24 → 2027-06 | Ouvrir |
| NCT07703462 Personalized Antisense Oligonucleotide Therapy for a Participant With T… |
nL-TARDB-002 | Sclérose latérale amyotrophique | Phase 1/2 | ENROLLING_BY_INVITATION | En attente / non publié | n-Lorem Foundation | United States · Jefferson Health, Philadelphia, Unite… | 2026-12 → 2028-12 | Ouvrir |
| NCT07680361 TETRAJACO — Study of Home Use of the Jaco Robotic Manipulation Device b… |
Use of the JACO robotic arm for a… | Sclérose latérale amyotrophique | Non applicable | COMPLETED | En attente / non publié | Association APPROCHE | France · Centre Bouffard Vercelli, Perpignan, France | 2022-03-30 → 2023-04-21 | Ouvrir |
| NCT06209515 DEGERWD — Sociodemographic Factors and Criminal Behaviour Preceding Neu… |
DEGERWD — Sociodemographic Factor… | Sclérose latérale amyotrophique | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | Kuopio University Hospital | Finland · Kuopio University Hospital, Kuopio, Finland | 2022-01-01 → 2029-12-31 | Ouvrir |
| NCT06106672 Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP… |
CNP-106 | Myasthénie | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | COUR Pharmaceutical Development C… | United States · Atlantis Research, Miami, United Stat… | 2024-05-30 → 2026-08 | Ouvrir |
| NCT07429240 PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne… |
PBGENE-DMD (IV) | Myopathies | Phase 1/2 | RECRUITING | En attente / non publié | Precision BioSciences, Inc. | United States · Arkansas Children's Hospital, Little … | 2026-04-24 → 2029-12 | Ouvrir |
| NCT06280209 A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics,… |
BMN 351 | Myopathies | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | BioMarin Pharmaceutical | Italy, Netherlands, Spain, Turkey (Türkiye), United K… | 2024-01-03 → 2027-04-14 | Ouvrir |
| NCT07673809 A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Ge… |
GNR-097 | Myopathies | Phase 1/2 | RECRUITING | En attente / non publié | AO GENERIUM | Belarus, Russia · National Medical Research Center fo… | 2025-09-30 → 2029-08-02 | Ouvrir |
| NCT06138639 A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE… |
SGT-003 | Myopathies | Phase 1/2 | RECRUITING | En attente / non publié | Solid Biosciences Inc. | United States, Canada, Italy, United Kingdom · Ann & … | 2024-05-06 → 2031-05-06 | Ouvrir |
| NCT05747924 FORTITUDE — Phase 1/2 Study of AOC 1020 in Participants With Facioscapu… |
AOC 1020 | Myopathies | Phase 1/2 | COMPLETED | En attente / non publié | Avidity Biosciences, Inc. | United States, Canada, United Kingdom · Duke Universi… | 2023-04-04 → 2026-03-20 | Ouvrir |